Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

59
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
59
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines01:21

Vaccines

46
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
46
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccinations01:51

Vaccinations

54.0K
Overview
54.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Phenotypic and Genomic Study for Understanding the Variability in Susceptibility of Listeria monocytogenes to AMPs and Bacteriocins.

Probiotics and antimicrobial proteins·2026
Same author

The paradox of <i>Abundance:</i> Hafeez Lakhani's novel and Riz Ahmed's series <i>Bait</i> on the cost of the immigrant dream.

BMJ (Clinical research ed.)·2026
Same author

A Biomimetic Microfluidic Triple-compartment Periodontium-on-chip for Investigation of Inflammatory Responses in Periodontitis.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

The inflamed new adaptation of <i>Wuthering Heights</i> misses the book's elemental understanding of body and mind.

BMJ (Clinical research ed.)·2026
Same author

TranscriptFormer: A generative cell atlas across 1.5 billion years of evolution.

Science (New York, N.Y.)·2026
Same author

What is diagnosis in the age of artificial intelligence.

Diagnosis (Berlin, Germany)·2026

Related Experiment Video

Updated: Apr 3, 2026

High-throughput Titration of Luciferase-expressing Recombinant Viruses
08:09

High-throughput Titration of Luciferase-expressing Recombinant Viruses

Published on: September 19, 2014

13.5K

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Susan M Twine1, Kelly M Fulton1, John Spika2

  • 1a National Research Council Canada-Human Health Therapeutics (NRC-HHT) ; Ottawa , Ontario , Canada.

Human Vaccines & Immunotherapeutics
|September 19, 2015
PubMed
Summary

Advancing vaccine biomarker research requires collaboration to address challenges in pre-clinical and clinical studies. This workshop identified key gaps and opportunities for innovation in vaccine development and efficacy prediction.

Keywords:
assay validationbiomarkerscorrelates of protectionimmune monitoringimmunization strategysurrogate markersvaccine efficacyvaccine safetyvaccines

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.5K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.6K

Related Experiment Videos

Last Updated: Apr 3, 2026

High-throughput Titration of Luciferase-expressing Recombinant Viruses
08:09

High-throughput Titration of Luciferase-expressing Recombinant Viruses

Published on: September 19, 2014

13.5K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.5K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.6K

Area of Science:

  • Immunology
  • Vaccinology
  • Biomarker Discovery

Background:

  • Vaccine biomarkers are crucial for vaccine development, bridging pre-clinical to clinical studies, and predicting efficacy and adverse events.
  • Despite advancements, a comprehensive understanding of the human host response to vaccination remains incomplete.
  • The Next Generation Vaccine Biomarker workshop convened stakeholders to address these knowledge gaps.

Purpose of the Study:

  • To foster discussion and collaboration on advancing vaccine biomarker research.
  • To identify challenges and opportunities in vaccine biomarker discovery and application.
  • To outline future directions for vaccine biomarker research, particularly within the Canadian context.

Main Methods:

  • A two-day workshop was held, bringing together international and Canadian experts from industry, government, and academia.
  • Discussions were organized around key themes including pre-clinical and clinical biomarker challenges, veterinary vaccines, regulatory hurdles, and biomarkers for adjuvants and cancer vaccines.
  • Case studies were utilized to pinpoint specific needs and areas requiring innovation.

Main Results:

  • The workshop highlighted critical needs and gaps in current vaccine biomarker research.
  • Key areas for innovation were identified across various stages of vaccine development and application.
  • Collaborative opportunities were explored to accelerate vaccine biomarker discovery and implementation.

Conclusions:

  • Advancing vaccine biomarker research necessitates a collaborative approach involving diverse stakeholders.
  • Addressing identified gaps through targeted innovation is essential for improving vaccine development and efficacy.
  • Strategic initiatives, especially within the Canadian research landscape, are needed to move the field forward.